istock-625061004_warchicompliance

Warchi /iStockphoto.com

19 December 2017Big Pharma

European Commission closes Roche investigation

The European Commission has closed an investigation into Roche which centred on the company’s pharmacovigilance duties.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Judge cuts ‘disproportionate’ £1.7m costs claim by Roche

27 July 2021 Roche has drawn criticism from an English High Court judge over its ‘disproportionate” demand for nearly $2.3m in costs, after it won a patent dispute with medical device company Insulet over a tubeless insulin pump.

EMA concludes drug monitoring probe against Roche

5 July 2016 The European Medicines Agency announced yesterday that it has concluded its second inquiry in its case against pharmaceutical company Roche centring on the company’s pharmacovigilance duties.

More on this story

Judge cuts ‘disproportionate’ £1.7m costs claim by Roche

27 July 2021 Roche has drawn criticism from an English High Court judge over its ‘disproportionate” demand for nearly $2.3m in costs, after it won a patent dispute with medical device company Insulet over a tubeless insulin pump.

EMA concludes drug monitoring probe against Roche

5 July 2016 The European Medicines Agency announced yesterday that it has concluded its second inquiry in its case against pharmaceutical company Roche centring on the company’s pharmacovigilance duties.

More on this story

Judge cuts ‘disproportionate’ £1.7m costs claim by Roche

27 July 2021 Roche has drawn criticism from an English High Court judge over its ‘disproportionate” demand for nearly $2.3m in costs, after it won a patent dispute with medical device company Insulet over a tubeless insulin pump.

EMA concludes drug monitoring probe against Roche

5 July 2016 The European Medicines Agency announced yesterday that it has concluded its second inquiry in its case against pharmaceutical company Roche centring on the company’s pharmacovigilance duties.

More features

Life sciences leaders recognised at LSPN Awards USA 2025

UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body

LSPN: Counsel grapple with AI’s impact on training and critical thinking

'Nothing can stand in the way of our work': Ukraine resumes IP system

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB